These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 37637068)
21. Subtype-based analysis of cell-in-cell structures in non-small cell lung cancer. Wei Y; Niu Z; Hou X; Liu M; Wang Y; Zhou Y; Wang C; Ma Q; Zhu Y; Gao X; Li P; Gao S; Zhan S; Yang Z; Tai Y; Shao Q; Ge J; Hua J; Gao L; Sun Q; Jiang H; Huang H Am J Cancer Res; 2023; 13(3):1091-1102. PubMed ID: 37034205 [TBL] [Abstract][Full Text] [Related]
22. A global collaboRAtive study of CIC-rearranged, BCOR::CCNB3-rearranged and other ultra-rare unclassified undifferentiated small round cell sarcomas (GRACefUl). Palmerini E; Gambarotti M; Italiano A; Nathenson MJ; Ratan R; Dileo P; Provenzano S; Jones RL; DuBois SG; Martin-Broto J; de Alava E; Baldi GG; Grignani G; Ferraresi V; Brunello A; Paoluzzi L; Bertulli R; Hindi N; Montemurro M; Rothermundt C; Cocchi S; Salguero-Aranda C; Donati D; Martin JD; Abdelhamid Ahmed AH; Mazzocca A; Carretta E; Cesari M; Pierini M; Righi A; Sbaraglia M; Laginestra MA; Scotlandi K; Dei Tos AP; Ibrahim T; Stacchiotti S; Vincenzi B Eur J Cancer; 2023 Apr; 183():11-23. PubMed ID: 36791667 [TBL] [Abstract][Full Text] [Related]
24. Capicua in Human Cancer. Kim JW; Ponce RK; Okimoto RA Trends Cancer; 2021 Jan; 7(1):77-86. PubMed ID: 32978089 [TBL] [Abstract][Full Text] [Related]
25. CIC-Rearranged Sarcomas: An Intriguing Entity That May Lead the Way to the Comprehension of More Common Cancers. Mancarella C; Carrabotta M; Toracchio L; Scotlandi K Cancers (Basel); 2022 Nov; 14(21):. PubMed ID: 36358827 [TBL] [Abstract][Full Text] [Related]
26. Making heads or tails - the emergence of capicua (CIC) as an important multifunctional tumour suppressor. Wong D; Yip S J Pathol; 2020 Apr; 250(5):532-540. PubMed ID: 32073140 [TBL] [Abstract][Full Text] [Related]
27. The Capicua tumor suppressor: a gatekeeper of Ras signaling in development and cancer. Simón-Carrasco L; Jiménez G; Barbacid M; Drosten M Cell Cycle; 2018; 17(6):702-711. PubMed ID: 29578365 [TBL] [Abstract][Full Text] [Related]
28. Clinicopathological features of five cases of CIC::DUX4 positive sarcomas, including literature review. Rekhi B; Rumdee R; Shetty O Ann Diagn Pathol; 2023 Aug; 65():152153. PubMed ID: 37167753 [TBL] [Abstract][Full Text] [Related]
29. CD44/CD44v6 a Reliable Companion in Cancer-Initiating Cell Maintenance and Tumor Progression. Wang Z; Zhao K; Hackert T; Zöller M Front Cell Dev Biol; 2018; 6():97. PubMed ID: 30211160 [TBL] [Abstract][Full Text] [Related]
30. Defects in innate immunity render breast cancer initiating cells permissive to oncolytic adenovirus. Ahtiainen L; Mirantes C; Jahkola T; Escutenaire S; Diaconu I; Osterlund P; Kanerva A; Cerullo V; Hemminki A PLoS One; 2010 Nov; 5(11):e13859. PubMed ID: 21079774 [TBL] [Abstract][Full Text] [Related]
31. Immune complexes and human neoplasia. Salinas FA; Wee KH; Silver HK Biomed Pharmacother; 1983; 37(5):211-8. PubMed ID: 6362736 [TBL] [Abstract][Full Text] [Related]
32. Capicua suppresses YAP1 to limit tumorigenesis and maintain drug sensitivity in human cancer. Kim JW; Luck C; Wu W; Ponce RK; Lin YK; Gupta N; Okimoto RA Cell Rep; 2022 Oct; 41(1):111443. PubMed ID: 36198276 [TBL] [Abstract][Full Text] [Related]
33. [Circulating immune complexes in breast cancer]. Abecassis J; Petit JC; Eber M; Klein T; Rodier D; Janser JC; Methlin G Bull Cancer; 1985; 72(1):42-7. PubMed ID: 3872691 [TBL] [Abstract][Full Text] [Related]
34. Lipomyelomeningocele for the urologist: Should we view it the same as myelomeningocele? Yerkes EB; Halline C; Yoshiba G; Meyer TA; Rosoklija I; Bowman R; McLone D; Cheng EY J Pediatr Urol; 2017 Aug; 13(4):371.e1-371.e8. PubMed ID: 28583853 [TBL] [Abstract][Full Text] [Related]
35. The importance of basidiomycetous fungi cultured from the sputum of chronic idiopathic cough: a study to determine the existence of recognizable clinical patterns to distinguish CIC from non-CIC. Ogawa H; Fujimura M; Takeuchi Y; Makimura K Respir Med; 2009 Oct; 103(10):1492-7. PubMed ID: 19473825 [TBL] [Abstract][Full Text] [Related]
36. ETV4 is a useful marker for the diagnosis of CIC-rearranged undifferentiated round-cell sarcomas: a study of 127 cases including mimicking lesions. Le Guellec S; Velasco V; Pérot G; Watson S; Tirode F; Coindre JM Mod Pathol; 2016 Dec; 29(12):1523-1531. PubMed ID: 27562494 [TBL] [Abstract][Full Text] [Related]
37. Distinct subpopulations of head and neck cancer cells with different levels of intracellular reactive oxygen species exhibit diverse stemness, proliferation, and chemosensitivity. Chang CW; Chen YS; Chou SH; Han CL; Chen YJ; Yang CC; Huang CY; Lo JF Cancer Res; 2014 Nov; 74(21):6291-305. PubMed ID: 25217518 [TBL] [Abstract][Full Text] [Related]
38. Capicua suppresses colorectal cancer progression via repression of ETV4 expression. Lee JS; Kim E; Lee J; Kim D; Kim H; Kim CJ; Kim S; Jeong D; Lee Y Cancer Cell Int; 2020; 20():42. PubMed ID: 32042269 [TBL] [Abstract][Full Text] [Related]
39. Comparative transcriptome analysis of isogenic cell line models and primary cancers links capicua (CIC) loss to activation of the MAPK signalling cascade. LeBlanc VG; Firme M; Song J; Chan SY; Lee MH; Yip S; Chittaranjan S; Marra MA J Pathol; 2017 Jun; 242(2):206-220. PubMed ID: 28295365 [TBL] [Abstract][Full Text] [Related]
40. Review with novel markers facilitates precise categorization of 41 cases of diagnostically challenging, "undifferentiated small round cell tumors". A clinicopathologic, immunophenotypic and molecular analysis. Machado I; Yoshida A; Morales MGN; Abrahão-Machado LF; Navarro S; Cruz J; Lavernia J; Parafioriti A; Picci P; Llombart-Bosch A Ann Diagn Pathol; 2018 Jun; 34():1-12. PubMed ID: 29661713 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]